WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512)

Market cap
¥11.8B
P/E ratio
51.4x
Wakamoto Pharmaceutical manufactures branded drugs, generic medicines, and health products like Koryoku Wakamoto for healthcare providers and consumers in Japan and internationally.
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 202612,009+3.43%
Mar 31, 202511,610-3.46%
Mar 31, 202412,026+1.00%
Mar 31, 202311,907+3.71%
Mar 31, 202211,481+0.84%
Mar 31, 202111,386-4.70%
Mar 31, 202011,947-13.18%
Mar 31, 201913,761-2.45%
Mar 31, 201814,107+1.52%
Mar 31, 201713,897-0.42%
Mar 31, 201613,955-1.20%
Mar 31, 201514,124+2.26%
Mar 31, 201413,813
AI Chat